Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 32, Issue 3, 2012, Pages 677-687

  Zhang, Quan ^a,c   Stafford, Randall B ^a,b   Wang, Ze ^a,b   Arnold, Steven E ^b   Wolk, David A ^a,b   Detre, John A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; arterial spin labeling; cerebral blood flow; magnetic resonance imaging; perfusion; vascular cognitive impairment; white matter lesions

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTERIAL SPIN LABELED PERFUSION MAGNETIC RESONANCE IMAGING; ARTICLE; BRAIN BLOOD FLOW; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; REPRODUCIBILITY; RETROSPECTIVE STUDY; WHITE MATTER; WORD LIST RECALL;

EID: 84872250040     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120964     Document Type: Article

References (76)

1. Querfurth HW, LaFerla FM (2010) alzheimer's disease. N Engl J Med 362, 329-344.
2. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, HofmanAet al. (1993)Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260. (Pubitemid 23060253)
3. Kling MA, Trojanowski JQ, Wolk DA, Lee V-Y, Arnold SE (2012) Vascular disease and dementias: Paradigm shifts to drive research in new directions. Alzheimers Dementia, in press
4. Sahathevan R, Brodtmann A, Donnan GA (2012) Dementia, stroke, and vascular risk factors; A review. Int J Stroke 7, 61-73.
5. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S (2011) Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the american heart association/american stroke association. Stroke 42, 26722713.
6. Iadecola C (2010) The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 120, 287-296.
7. Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, Mungas D, Reed BR, Kramer JH, Decarli CC, Weiner MW, Vinters HV (2006) Cognitive impact of subcortical vascular and alzheimer's disease pathology. Ann Neurol 60, 677-687. (Pubitemid 46048485)
8. Petrovitch H, Ross GW, Steinhorn SC, Abbott RD, Markesbery W, Davis D, Nelson J, Hardman J, Masaki K, Vogt MR, Launer L, White LR (2005) AD lesions and infarcts in demented and non-Demented Japanese-American men. Ann Neurol 57, 98-103. (Pubitemid 40053320)
9. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of alzheimer disease The Nun Study. JAMA 277, 813-817. (Pubitemid 27111317)
10. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Cerebral infarctions and the likelihood of dementia from alzheimer disease pathology. Neurology 62, 11481155. (Pubitemid 38456510)
11. Schneider JA, Arvanitakis Z, Leurgans SE, BennettDA(2009) The neuropathology of probable alzheimer disease and mild cognitive impairment. Ann Neurol 66, 200-208.
12. Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, Braak H, Kokmen E (2006) Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 63, 665672.
13. RomanG(2003)Vascular dementia:Ahistorical background. Int Psychogeriatr 15(Suppl 1), 11-13.
14. Launer LJ, RossGW, Petrovitch H, Masaki K, FoleyD,White LR, Havlik RJ (2000) Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging 21, 49-55. (Pubitemid 30224785)
15. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H (2002) Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-Life alzheimer disease. Ann Intern Med 137, 149-155. (Pubitemid 34827510)
16. MahleyRW,Weisgraber KH, HuangY(2006) Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including alzheimer's disease. Proc Natl Acad Sci U S A 103, 5644-5651.
17. Iadecola C, GorelickPB(2003) Converging pathogenic mechanisms in vascular and neurodegenerative dementia. Stroke 34, 335-337. (Pubitemid 36206315)
18. Iadecola C, Davisson RL (2008) Hypertension and cerebrovascular dysfunction. Cell Metab 7, 476-484. (Pubitemid 351729202)
19. Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y (2009) Contribution of vascular risk factors to the progression in alzheimer disease. Arch Neurol 66, 343-348.
20. Savva GM, Stephan BC (2010) Epidemiological studies of the effect of stroke on incident dementia:Asystematic review. Stroke 41, e41-e46.
21. Beach TG,Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, Pandya Y, Esh C, Connor DJ, Sabbagh M, Walker DG, RoherAE(2007) Circle ofWillis atherosclerosis: Association with alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol 113, 13-21. (Pubitemid 44782925)
22. Honig LS, Kukull W, Mayeux R (2005) Atherosclerosis and AD: Analysis of data from theUSNational alzheimer's Coordinating Center. Neurology 64, 494-500. (Pubitemid 40189869)
23. Garcia-Alloza M, Gregory J, Kuchibhotla KV, Fine S,Wei Y, Ayata C, Frosch MP, Greenberg SM, Bacskai BJ (2011) Cerebrovascular lesions induce transient beta-Amyloid deposition. Brain 134, 3697-3707.
24. Wen Y, Yang SH, Liu R, Perez EJ, Brun-Zinkernagel AM, Koulen P, Simpkins JW (2007) Cdk5 is involved in NFT-Like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta 1772, 473-483. (Pubitemid 46400382)
25. de la Torre JC (2008) Pathophysiology of neuronal energy crisis in alzheimer's disease. Neurodegener Dis 5, 126132. (Pubitemid 351347829)
26. de la Torre JC, Mussivand T (1993) Can disturbed brain microcirculation cause alzheimer's disease? Neurol Res 15, 146-153. (Pubitemid 23166998)
27. de la Torre JC (2000) Critically attained threshold of cerebral hypoperfusion: The CATCH hypothesis of alzheimer's pathogenesis. Neurobiol Aging 21, 331-342. (Pubitemid 30387092)
28. de la Torre JC (2010) The vascular hypothesis of alzheimer's disease: Bench to bedside and beyond. Neurodegener Dis 7, 116-121.
29. de la Torre JC (2012)Aturning point for alzheimer's disease? Biofactors 38, 78-83.
30. Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M,Winblad B, Coley N, Vellas B (2011) Biomarkers for alzheimer's disease therapeutic trials. Prog Neurobiol 95, 579-593.
31. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55, 306-319. (Pubitemid 38269583)
32. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
33. Gouw AA, Seewann A, van der Flier WM, Barkhof F, Rozemuller AM, Scheltens P, Geurts JJ (2011) Heterogeneity of small vessel disease: A systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 82, 126-135.
34. Kim JH, Hwang KJ, Lee YH, Rhee HY, Park KC (2011) Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild alzheimer's disease. J Clin Neurosci 18, 1101-1106.
35. Farrall AJ, Wardlaw JM (2009) Blood-Brain barrier: Ageing and microvascular disease-Systematic review and metaanalysis. Neurobiol Aging 30, 337-352.
36. Zlokovic BV (2008) The blood-Brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201.
37. Sperling RA, Jack CR Jr, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJ (2011) Amyloid-Related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement 7, 367-385.
38. Schrag M, McAuleyG, Pomakian J, Jiffry A, Tung S, Mueller C, Vinters HV, Haacke EM, Holshouser B, Kido D, Kirsch WM (2010) Correlation of hypointensities in susceptibilityweighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: A postmortem MRI study. Acta Neuropathol 119, 291-302.
39. Nandigam RN, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J, Greenberg SM, Dickerson BC (2009) MR imaging detection of cerebral microbleeds: Effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 30, 338-343.
40. Williams DS, Detre JA, Leigh JS, Koretsky AP (1992) Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A 89, 212-216.
41. Detre JA, Leigh JS,Williams DS, Koretsky AP (1992) Perfusion imaging. Magn Reson Med 23, 37-45.
42. Ye FQ, Berman KF, Ellmore T, Esposito G, van Horn JD, Yang Y, Duyn J, Smith AM, Frank JA, Weinberger DR, McLaughlin AC (2000) H(2)(15)O PET validation of steadystate arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med 44, 450-456.
43. Xu G, Rowley HA, Wu G, Alsop DC, Shankaranarayanan A, Dowling M, Christian BT, Oakes TR, Johnson SC (2010) Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15Owater PET in elderly subjects at risk for alzheimer's disease. NMR Biomed 23, 286-293.
44. Alsop DC, DaiW, Grossman M, Detre JA(2010) Arterial spin labeling blood flowMRI: Its role in the early characterization of alzheimer's disease. J Alzheimers Dis 20, 871-880.
45. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N (2005) Pattern of cerebral hypoperfusion in alzheimer disease and mild cognitive impairment measured with arterial spin-Labeling MR imaging: Initial experience. Radiology 234, 851-859. (Pubitemid 40250829)
46. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM (2009) Mild cognitive impairment and alzheimer disease: Patterns of altered cerebral blood flow at MR imaging. Radiology 250, 856-866.
47. Firbank MJ, He J, Blamire AM, Singh B, Danson P, Kalaria RN, O'Brien JT (2011) Cerebral blood flow by arterial spin labeling in poststroke dementia. Neurology 76, 1478-1484.
48. van Gelderen P, de Zwart JA, Duyn JH (2008) Pittfalls of MRI measurement of white matter perfusion based on arterial spin labeling. Magn Reson Med 59, 788-795. (Pubitemid 351501944)
49. Wang J, Alsop DC, Li L, Listerud J, Gonzalez-At JB, Schnall MD, Detre JA (2002) Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magn Reson Med 48, 242-254. (Pubitemid 34809412)
50. Wang J, Zhang Y, Wolf RL, Roc AC, Alsop DC, Detre JA (2005) Amplitude-modulated continuous arterial spinlabeling 3.0-T perfusion MR imaging with a single coil: Feasibility study. Radiology 235, 218-228. (Pubitemid 40432258)
51. Dai W, Garcia D, de Bazelaire C, Alsop DC (2008) Continuous flow-Driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 60, 1488-1497.
52. Chen Y, Wang DJ, Detre JA (2011) Test-Retest reliability of arterial spin labeling with common labeling strategies.JMagn Reson Imaging 33, 940-949.
53. van Osch MJ, Teeuwisse WM, van Walderveen MA, Hendrikse J, Kies DA, van Buchem MA (2009) Can arterial spin labeling detect white matter perfusion signal? Magn Reson Med 62, 165-173.
54. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
55. PetersenRC(2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183-194. (Pubitemid 39222988)
56. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment-Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-246. (Pubitemid 39222993)
57. Wang J, Alsop DC, Song HK, Maldjian JA, Tang K, Salvucci AE, Detre JA (2003) Arterial transit time imaging with flow encoding arterial spin tagging (FEAST). Magn Reson Med 50, 599-607. (Pubitemid 37082085)
58. Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32, 1207-1218.
59. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J (1993) A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114, 7-12. (Pubitemid 23025201)
60. Bland JM, Altman DG (1996) Measurement error proportional to the mean. BMJ 313, 106. (Pubitemid 26257767)
61. Alsop DC, Detre JA, Grossman M (2000) Assessment of cerebral blood flow in alzheimer's disease by spin-Labeled magnetic resonance imaging. Ann Neurol 47, 93-100. (Pubitemid 30033655)
62. Yoshiura T, Hiwatashi A, Yamashita K, Ohyagi Y, Monji A, Takayama Y, Nagao E, Kamano H, Noguchi T, Honda H (2009) Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-Labeling in patients with alzheimer disease. AJNR Am J Neuroradiol 30, 1388-1393.
63. Dobre MC, Ugurbil K, Marjanska M (2007) Determination of blood longitudinal relaxation time (T1) at high magnetic field strengths. Magn Reson Imaging 25, 733-735. (Pubitemid 46817806)
64. Ko L, Salluzzi M, Frayne R, Smith M (2007) Reexamining the quantification of perfusion MRI data in the presence of bolus dispersion. J Magn Reson Imaging 25, 639-643. (Pubitemid 46355428)
65. DaiW, Robson PM, Shankaranarayanan A, Alsop DC (2012) Reduced resolution transit delay prescan for quantitative continuous arterial spin labeling perfusion imaging. Magn Reson Med 67, 1252-1265.
66. Wells JA, Lythgoe MF, Gadian DG, Ordidge RJ, Thomas DL (2010) In vivo Hadamard encoded continuous arterial spin labeling (H-CASL). Magn Reson Med 63, 1111-1118.
67. Dai W, Shankaranarayanan A, Alsop DC (2012) Volumetric measurement of perfusion and arterial transit delay using hadamard encoded continuous arterial spin labeling. Magn Reson Med, doi: 10.1002/mrm.24335.
68. Wu WC, Edlow BL, Elliot MA, Wang J, Detre JA (2009) Physiological modulations in arterial spin labeling perfusion magnetic resonance imaging. IEEE Trans Med Imaging 28, 703-709.
69. Moody DM, Bell MA, Challa VR (1990) Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: An anatomic study. AJNR Am J Neuroradiol 11, 431-439. (Pubitemid 20232817)
70. Artero S, Tiemeier H, Prins ND, Sabatier R, Breteler MM, Ritchie K (2004) Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly. J Neurol Neurosurg Psychiatry 75, 1304-1308. (Pubitemid 39141339)
71. Targosz-Gajniak M, Siuda J, Ochudlo S, OpalaG(2009) Cerebral white matter lesions in patients with dementia - from MCI to severe alzheimer's disease. J Neurol Sci 283, 79-82.
72. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L (1996) Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people The Cardiovascular Health Study. Stroke 27, 1274-1282. (Pubitemid 26286152)
73. Moody DM, Brown WR, Challa VR, Ghazi-Birry HS, Reboussin DM (1997) Cerebral microvascular alterations in aging, leukoaraiosis, and alzheimer's disease. Ann N Y Acad Sci 826, 103-116.
74. Kalaria RN (1992) The blood-Brain barrier and cerebral microcirculation in alzheimer disease. Cerebrovasc Brain Metab Rev 4, 226-260.
75. Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, Rosand J, Growdon JH, Greenberg SM (2006) Plasma beta-Amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 66, 2329.
76. Debette S, Markus HS (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: Systematic review and meta-Analysis. BMJ 341, c3666.